|
| (1S,2S,3S,5S)-5-(2-Amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-(benzyloxymethyl)cyclopentanol Basic information |
Product Name: | (1S,2S,3S,5S)-5-(2-Amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-(benzyloxymethyl)cyclopentanol | Synonyms: | (1S,2S,3S,5S)-5-(2-Amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-(benzyloxymethyl)cydopentanol;(1S,2S,3S,5S)-5-(2-Amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-(benzyloxymethyl)cyclopentanol;(1S,2S,3S,5S)-5-(2-Amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-(benzyloxymethyl)cyclopentanol ,98%;(1S,2R,3S,5S)-5-(2-amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-(benzyloxymethyl)cyclopentanol;(1S,2S,3S,5S)-5-(2-AMino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-(benzyloxyMethyl)cyclopentanol (interMediate step 3);Entecavir InterMediate IV;Entecavir-4;(1S,2S,3S,5S)-5-(2-Amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-(benzyloxymethyl)cyclopenta | CAS: | 142217-77-4 | MF: | C32H33N5O4 | MW: | 551.64 | EINECS: | 1312995-182-4 | Product Categories: | | Mol File: | 142217-77-4.mol | |
| (1S,2S,3S,5S)-5-(2-Amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-(benzyloxymethyl)cyclopentanol Chemical Properties |
Boiling point | 780.5±70.0 °C(Predicted) | density | 1.33 | storage temp. | Keep in dark place,Inert atmosphere,Room temperature | form | Oil | pka | 13.88±0.70(Predicted) | color | Clear | CAS DataBase Reference | 142217-77-4(CAS DataBase Reference) |
| (1S,2S,3S,5S)-5-(2-Amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-(benzyloxymethyl)cyclopentanol Usage And Synthesis |
Uses | (2R,3R,5R)-5-[2-Amino-6-(phenylmethoxy)-9H-purin-9-yl]-3-(phenylmethoxy)-2-[(phenylmethoxy)methyl]-cyclopentanol is an intermediate in the preparation of ent-Entecavir (E558905). |
| (1S,2S,3S,5S)-5-(2-Amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-(benzyloxymethyl)cyclopentanol Preparation Products And Raw materials |
|